January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreNovember 01, 2025
Market insights predict the global animal genetics industry will increase from USD 6.51 billion in 2024 to USD 12.11 billion by 2034, achieving a CAGR of 6.4%. In 2024, North America led the animal genetics market with a 32% share, while Asia-Pacific is set for the fastest growth. Cattle dominated by animal type, but companion animals will grow the...
November 01, 2025
Market insights predicts the genetic material market is set for strong growth from 2025 to 2034, driven by gene therapies, personalized medicine, and biopharma research. North America led in 2024, while Asia Pacific will grow fastest. DNA dominated, but RNA is rising. Genomics led in 2024, with drug discovery and pharma seeing major expansion....
November 01, 2025
Based on market forecasts, the plasmid purification sector will expand from USD 1.95 billion in 2024 to USD 5.88 billion by 2034, experiencing a CAGR of 11.64%. In 2024, North America led the plasmid purification market with a 41% share, while Asia Pacific is set for the fastest growth. Products dominated, but services will expand rapidly. Molecula...
November 01, 2025
Based on market forecasts, the genome sequencing sector will expand from USD 22.63 billion in 2024 to USD 101.93 billion by 2034, experiencing a CAGR of 16.24%. In 2024, North America led the genome sequencing market, with consumables and next-generation sequencing as key segments. The clinical and academic research sectors dominated. Asia Pacific ...
November 01, 2025
According to market projections, the cell line development sector is expected to grow from USD 5.86 billion in 2024 to USD 14.92 billion by 2034, reflecting a CAGR of 9.85%. In 2024, North America led the cell line development market, with Asia Pacific growing fastest. Reagents & media and mammalian cell lines dominated, while services, hybrido...
November 01, 2025
Projections indicate that, protein engineering industry is projected to rise from USD 3.08 billion in 2024 to USD 13.84 billion by 2034, reflecting a CAGR of 16.27% over the next decade. Drug discovery platforms use smart tech to deliver drugs more safely and effectively. With rising chronic diseases and a push for personalized treatments, the mark...
November 01, 2025
Projections indicate that, the global molecular cloning market will increase from USD 5.25 billion in 2024 to USD 8.89 billion by 2034, experiencing a CAGR of 5.4% over the next 10 years. Molecular cloning is used to produce identical DNA copies. Thus, it has various applications in biopharmaceuticals, genetic engineering, and agricultural producti...
November 01, 2025
According to market projections, the single-cell omics sector is expected to grow from USD 1.94 billion in 2024 to USD 12.05 billion by 2034, reflecting a CAGR of 16.14%. Omics is a highly essential field in drug discovery and the development of personalized treatments. Rising clinical trials to develop gene-based therapies are promoting growth in ...
November 01, 2025
According to market projections, the phosphoramidite sector is expected to grow from USD 1.2 billion in 2024 to USD 2.45 billion by 2034, reflecting a CAGR of 7.4%. Phosphoramidite is an essential part of DNA synthesis, which is used in various therapeutics, genetic engineering, and research, and has promoted the growth of the phosphoramidite marke...
November 01, 2025
Market insights predict the global single nucleotide polymorphism (SNP) genotyping industry will increase from USD 6.48 billion in 2024 to USD 19.48 billion by 2034, achieving a CAGR of 11.7%. The single nucleotide polymorphism (SNP) genotyping market is expanding due to rising genetic disorders as well as increasing developments in precision medic...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com